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PURPOSE: To determine any difference between bare metal stents (BMS) and balloon-
expandable covered stents in the treatment of innominate artery atheromatous lesions.
MATERIALS AND METHODS: A multicenter retrospective study involving 13
university hospitals in France collected 93 patients (mean age 63.2±11.1 years; 57
men) treated over a 10-year period. All patients had systolic blood pressure asymmetry
>15 mm Hg and were either asymptomatic (39, 42%) or had carotid (20, 22%),
vertebrobasilar (24, 26%), and/or brachial (20, 22%) symptoms. Innominate artery
stenosis ranged from 50% to 70% in 4 (4%) symptomatic cases and between 70% and
90% in 52 (56%) cases; 28 (30%) lesions were preocclusive and 8 (9%) were occluded.
One (1%) severely symptomatic patient had a <50% stenosis. Demographic
characteristics, operative indications, and procedure details were compared between
the covered (36, 39%) and BMS (57, 61%) groups. Multivariate analysis was performed
to determine relative risks of restenosis and reinterventions [reported with 95%
confidence intervals (CI)].
RESULTS: The endovascular procedures were performed mainly via retrograde carotid
access (75, 81%). Perioperative strokes occurred in 4 (4.3%) patients. During the mean
34.5±31.2-month follow-up, 30 (32%) restenoses were detected and 13 (20%)
reinterventions were performed. Relative risks were 6.9 (95% CI 2.2 to 22.2, p=0.001)
for restenosis and 14.6 (95% CI 1.8 to 120.8, p=0.004) for reinterventions between
BMS and covered stents. The severity of the treated lesions had no influence on the
results.
CONCLUSION: Patients treated with BMS for innominate artery stenosis have more
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